Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to clinical complete response

被引:0
|
作者
Suzuki, Shuhei [1 ]
Ito, Yuriko [1 ]
Fukui, Tadahisa [1 ]
Orihara, Mika [1 ]
Nakamura, Sho [1 ]
Takahashi, Masahiro [1 ]
Fujimoto, Hiroto [2 ]
Kimura, Wataru [2 ]
Yoshioka, Takashi [1 ]
机构
[1] Yamagata Univ, Yamagata Fac Med, Dept Clin Oncol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan
[2] Yamagata Univ, Yamagata Fac Med, Dept Surg 1, Yamagata, Japan
来源
INTERNATIONAL CANCER CONFERENCE JOURNAL | 2013年 / 2卷 / 04期
关键词
Gastric cancer; Clinical complete response; Cisplatin; S-1; Chemotherapy;
D O I
10.1007/s13691-013-0090-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to a clinical complete response (cCR). In case 1, a 60-year-old woman achieved a cCR after 6 cycles of S-1 and cisplatin. Eight cycles of S-1 and cisplatin and 16 cycles of S-1 alone were administered. Since treatment with S-1 alone, only observation has been performed with no recurrence. In case 2, a 63-year-old man achieved cCR after 2 cycles of S-1 and cisplatin chemotherapy. After 8 cycles of chemotherapy, cCR was confirmed, and a curative operation was performed. After surgery, a small number of viable cells were found in the pathological examination. Fifty-four reports of cCR cases of advanced non-resectable or metastatic gastric cancer with chemotherapy have been published, but none mentioned the treatment options after cCR. In this report, we show two patients choosing different paths after achieving cCR by chemotherapy. In our surgical case, residues of pathologically viable cancer cells were confirmed, so surgery might be recommended after cCR, but further investigation will be needed.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [11] Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer
    Shunichi Tsujitani
    Kenji Fukuda
    Nobuaki Kaibara
    Gastric Cancer, 2003, 6 (Suppl 1) : 50 - 57
  • [12] Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer
    Jin Young Kim
    Young Rok Do
    Keon Uk Park
    Jong Gwang Kim
    Yee Soo Chae
    Min Kyoung Kim
    Kyung Hee Lee
    Hun Mo Ryoo
    Sung Hwa Bae
    Jin Ho Baek
    Hong Suk Song
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 527 - 532
  • [13] Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes
    Kitamura, Shinji
    Tanahashi, Toshihito
    Aoyagi, Eriko
    Nakagawa, Tadahiko
    Okamoto, Koichi
    Kimura, Tetsuo
    Miyamoto, Hiroshi
    Mitsui, Yasuhiro
    Rokutan, Kazuhito
    Muguruma, Naoki
    Takayama, Tetsuji
    ONCOLOGY, 2017, 93 (02) : 127 - 135
  • [14] Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer
    Kim, Jin Young
    Do, Young Rok
    Park, Keon Uk
    Kim, Jong Gwang
    Chae, Yee Soo
    Kim, Min Kyoung
    Lee, Kyung Hee
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Baek, Jin Ho
    Song, Hong Suk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 527 - 532
  • [15] Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy
    Kojima, Yoshiyuki
    Yamada, Yasuyuki
    Kamisawa, Hideyuki
    Sasaki, Shoichi
    Hayashi, Yutaro
    Kohri, Kenjiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (08) : 1123 - 1125
  • [16] Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin
    Akatsu Y.
    Saikawa Y.
    Kubota T.
    Yoshida M.
    Furukawa T.
    Otani Y.
    Kumai K.
    Kitajima M.
    Gastric Cancer, 2004, 7 (2) : 128 - 133
  • [17] A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1
    Nakamura, Rieko
    Saikawa, Yoshiro
    Kumagai, Koushi
    Kiyota, Tsuyoshi
    Ohashi, Masaki
    Yoshida, Masashi
    Kubota, Tetsuro
    Kumai, Koichiro
    Kitajima, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (04) : 295 - 299
  • [18] A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1
    Rieko Nakamura
    Yoshiro Saikawa
    Koushi Kumagai
    Tsuyoshi Kiyota
    Masaki Ohashi
    Masashi Yoshida
    Tetsuro Kubota
    Koichiro Kumai
    Masaki Kitajima
    International Journal of Clinical Oncology, 2007, 12 : 295 - 299
  • [19] Clinical Efficacy of Combination Intravenous and Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis
    Zhang, Suyun
    Feng, Rui
    Pan, Zhangchi
    Lin, Mengxin
    Huang, Xiaobing
    Jiang, Tao
    Xu, Qian
    Chen, Qiang
    Yang, Sheng
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018, 19 (12) : 946 - 952
  • [20] Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer
    Ina, Kenji
    Kataoka, Takae
    Takeuchi, Yuuki
    Fukuoka, Tomoki
    Miwa, Takaya
    Nishio, Tomoko
    Furuta, Ryuichi
    Masaki, Ayako
    Mori, Fumiko
    Kayukawa, Satoshi
    Nagao, Seiji
    Ando, Takafumi
    Goto, Hidemi
    ONCOLOGY REPORTS, 2008, 20 (02) : 259 - 264